MENU
+Compare
ELV
Stock ticker: NYSE
AS OF
Apr 25 closing price
Price
$421.68
Change
-$7.11 (-1.66%)
Capitalization
120.06B

ELV stock forecast, quote, news & analysis

Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of December 2024... Show more

ELV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Ad is loading...
A.I.Advisor
a Summary for ELV with price predictions
Apr 25, 2025

ELV in upward trend: price may ascend as a result of having broken its lower Bollinger Band on April 21, 2025

ELV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 40 cases where ELV's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 66 cases where ELV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

ELV moved above its 50-day moving average on April 22, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ELV advanced for three days, in of 318 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 210 cases where ELV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ELV moved out of overbought territory on April 04, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on April 17, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ELV as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ELV turned negative on April 04, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.054) is normal, around the industry mean (3.063). P/E Ratio (20.460) is within average values for comparable stocks, (17.509). Projected Growth (PEG Ratio) (0.863) is also within normal values, averaging (1.089). Dividend Yield (0.012) settles around the average of (0.020) among similar stocks. P/S Ratio (0.715) is also within normal values, averaging (0.684).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ELV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
published Dividends

ELV paid dividends on March 25, 2025

Elevance Health ELV Stock Dividends
А dividend of $1.71 per share was paid with a record date of March 25, 2025, and an ex-dividend date of March 10, 2025. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Unitedhealth Group (NYSE:UNH), Elevance Health (NYSE:ELV), Cigna Group (The) (NYSE:CI), CVS HEALTH Corp (NYSE:CVS), Humana (NYSE:HUM), Centene Corp (NYSE:CNC).

Industry description

Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.

Market Cap

The average market capitalization across the Managed Health Care Industry is 68.32B. The market cap for tickers in the group ranges from 3.42M to 451.47B. UNH holds the highest valuation in this group at 451.47B. The lowest valued company is HRAA at 3.42M.

High and low price notable news

The average weekly price growth across all stocks in the Managed Health Care Industry was -3%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was 1%. NEUE experienced the highest price growth at 6%, while IHGP experienced the biggest fall at -20%.

Volume

The average weekly volume growth across all stocks in the Managed Health Care Industry was -46%. For the same stocks of the Industry, the average monthly volume growth was 60% and the average quarterly volume growth was 8%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 45
P/E Growth Rating: 67
Price Growth Rating: 54
SMR Rating: 83
Profit Risk Rating: 77
Seasonality Score: 27 (-100 ... +100)
View a ticker or compare two or three
ELV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

a provider of life, hospital and medical insurance plans

Industry ManagedHealthCare

Profile
Fundamentals
Details
Industry
Managed Health Care
Address
220 Virginia Avenue
Phone
+1 833 401-1577
Employees
104900
Web
https://www.elevancehealth.com